Not Tagged
Not Tagged
['inflammatory,bowel', 'psoriasis', 'derm', 'selection,(-selectionlte),(-selection lte),(-selection-lte)', 'crohn', 'infliximab', 'ustekinumab', 'risan']
highlights from this new talk and sequencing in #crohns. risk:benefit considerations are dynamic &amp; depend on the severity and the phase of management. treat-to-target should guide therapy choice. progress in clinical immunology is helping with some choices. #ecco23 
Professor and Chief of GI, The University of Chicago Medicine. I specialize in and advocate for the care of IBD patients. My tweets are my own. (he/him)